India Poised to Lead Global Genomics Revolution: Report
India is well positioned to benefit from a $300 billion global patent expiry wave, says Vallum Capital report.
M
Markets
NEWS CARD
“India Poised to Lead Global Genomics Revolution: Report”
Read more on
www.entrepreneuroutreach.com/s/6960fc
29 Jul 2026
New Delhi, July 29 (IANS) India is uniquely positioned to capitalise on a global genomics revolution and a looming $300 billion patent expiry wave that is driving an aggressive wave of biopharma acquisitions, a report said on Wednesday.
India hosts more WHO-certified pharmaceutical manufacturing plants than any other country on earth and for three decades, the model has been consistent science invented in the West, scaled and delivered by India, the report from Vallum Capital said.
The huge patent expiry wave will present Indian manufacturers with their largest growth windows and the medicines that are going to expire are not small molecules, but biologics, gene therapies and precision oncology drugs.
